New classification for identifying HR myeloma based on cytogenetic abnormalities
Prof Casali speaking at the Forum Against Cancer Europe (FACE) 'Cross Border Healthcare' meeting on the 15th September 2010. Organised by the European Cancer Patient Coalition. Networking and sharing data across Europe particularly important in rare cancers.
New classification for identifying HR myeloma based on cytogenetic abnormalities
The case for global gender-neutral HPV vaccination
Boosting HPV vaccination in India: A call to action
Legislation – a powerful tool for promoting massive changes
Gaza's cancer patients: Navigating the dual struggle of illness and war
Tackling breast cancer screening in conservative communities
Cooperative training for medical staff in Côte d'Ivoire: The national radiotherapy and medical oncology center project
Post-diagnosis diet, nutrition and cancer prognosis
Cancer in emergencies: What can we do better to protect the most vulnerable?